Search results for "registries"

showing 10 items of 615 documents

Insufficient control of heart rate in stable coronary artery disease patients in Latvia

2014

Background and objective:\ud Heart rate (HR) ≥70 beats per minute (bpm) increases cardiovascular risk in coronary artery disease (CAD) patients. The objective of the analysis is to characterize HR as well as other clinical parameters in outpatients with stable CAD in Latvia.<p></p>\ud \ud Materials and methods:\ud CLARIFY is an ongoing international registry of outpatients with established CAD. Latvian data regarding 120 patients enrolled in CLARIFY and collected at baseline visit during 2009–2010 were analyzed.<p></p>\ud \ud Results:\ud The mean HR was 67.7 ± 9.5 and 66.9 ± 10.7 bpm when measured by pulse palpation and electrocardiography, respectively. HR &#8…

Malemedicine.medical_specialtyAdrenergic beta-AntagonistsHeart rateCoronary artery diseaseAngina PectorisNOCoronary artery diseaseElectrocardiographyInternal medicineHeart ratemedicineHumansRegistriesCarvedilolAgedMetoprololHeart FailureMedicine(all)lcsh:R5-920Framingham Risk ScoreCoronary artery disease; Heart rate; Outpatient; Medicine (all)business.industryMedicine (all)OutpatientMiddle Agedmedicine.diseaseLatviaNebivololTreatment OutcomeBisoprololHeart failureAutomotive EngineeringCardiologycardiovascular systemFemalelcsh:Medicine (General)businessHeart rate; Coronary artery disease; Outpatienthuman activitiesmedicine.drugcirculatory and respiratory physiologyMedicina
researchProduct

Prognostic impact of anemia according to frailty status in elderly patients with acute coronary syndromes.

2019

Aims Anemia is associated with poorer outcomes in patients with acute coronary syndromes (ACS), but the magnitude of this association in elderly patients remains poorly understood. No study has assessed the prognostic impact of anemia according to frailty status in this setting. Methods The LONGEVO-SCA registry included unselected ACS patients aged at least 80 years. A geriatric assessment was performed during hospitalization, including frailty assessment using the FRAIL scale. Anemia was defined by the WHO criteria. We evaluated the impact of anemia on 6-month mortality according to the presence of frailty. Results A total of 517 patients were assessed. Mean age was 84.3 years, and a total…

Malemedicine.medical_specialtyAgingTime FactorsAnemiaFrail Elderly030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicinePredictive Value of TestsRisk Factorshemic and lymphatic diseasesInternal medicinemedicineHumans030212 general & internal medicineProspective StudiesRegistriesAcute Coronary SyndromeProspective cohort studyGeriatric AssessmentAged 80 and overFrailtybusiness.industryIncidence (epidemiology)IncidenceHazard ratioAge FactorsAnemiaGeneral Medicinemedicine.diseasePrognosisSpainPredictive value of testsCohortObservational studyFemaleCardiology and Cardiovascular MedicineRisk assessmentbusinessJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct

Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival esti…

2017

Abstract Background Cancer registries (CRs) are fundamental for estimating cancer burden, evaluating screening and monitoring health service performance. Stage at diagnosis—an essential information item collected by CRs—has been made available, for the first time, by CRs participating in EUROCARE-5. We analysed the quality of this information and estimated stage-specific survival across Europe for CRs with good data quality. Data and methods Sixty-two CRs sent stage (as TNM, condensed TNM or extent of disease) for 15 cancers diagnosed in 2000–2007. We assessed the quality, partly by comparing stage according to the three systems. We also developed procedures to reconstruct stage (categories…

Malemedicine.medical_specialtyCancer ResearchStage at diagnosiSurvivalConcordanceCancer registrieCancer registries ; Data quality ; Stage at diagnosis ; SurvivalSocio-culturaleReproducibility of ResultPredictive Value of TestCancer registries; Data quality; Stage at diagnosis; Survival; Data Accuracy; Europe; Female; Humans; Male; Neoplasm Metastasis; Neoplasms; Predictive Value of Tests; Reproducibility of Results; Survival Analysis; Neoplasm Staging; Registries; Oncology; Cancer Research03 medical and health sciences0302 clinical medicineBreast cancerPredictive Value of TestsNeoplasmsmedicineotorhinolaryngologic diseasesCancer registriesHumans030212 general & internal medicineRegistriesStage (cooking)Neoplasm MetastasisIntensive care medicineSurvival analysisCancer stagingNeoplasm Stagingbusiness.industryData qualityReproducibility of ResultsStage at diagnosismedicine.diseaseSurvival AnalysisCancer registryData AccuracyClinical trialNeoplasm MetastasiEuropeOncology030220 oncology & carcinogenesisData qualityNeoplasmFemaleSurvival AnalysibusinessHumanEuropean journal of cancer (Oxford, England : 1990)
researchProduct

Tumor Marker Carbohydrate Antigen 125 Predicts Adverse Outcome After Transcatheter Aortic Valve Implantation

2013

ObjectivesThis study sought to predict the value of tumor marker carbohydrate antigen 125 (CA125) before and after transcatheter aortic valve implantation (TAVI) for all-cause death and a composite endpoint of death, admission for heart failure, myocardial infarction, and stroke (major adverse cardiac events [MACE]).BackgroundRisk stratification after TAVI remains challenging. The use of biomarkers in this setting represents an unmet need.MethodsCA125 was measured in 228 patients before and after TAVI. The association with outcomes was assessed using parametric Cox regression and joint modeling for baseline and longitudinal analyses, respectively. CA125 was evaluated as logarithm transforma…

Malemedicine.medical_specialtyCardiac CatheterizationTime FactorsAortic Valve InsufficiencyMyocardial InfarctionKaplan-Meier EstimateRisk AssessmentCA125Interquartile rangeRisk FactorsInternal medicineMedicineHumansMyocardial infarctionLongitudinal StudiesRegistriesStroketranscatheter aortic valve implantationTumor markerAgedProportional Hazards ModelsAged 80 and overHeart FailureHeart Valve Prosthesis ImplantationProportional hazards modelbusiness.industryMembrane ProteinsAortic Valve Stenosismedicine.diseasejoint modelingHospitalizationStrokeLogistic ModelsTreatment OutcomeCardiovascular DiseasesHeart failureCA-125 AntigenMultivariate AnalysisCardiologybiomarkerBiomarker (medicine)FemaleprognosisbusinessCardiology and Cardiovascular MedicineMaceBiomarkersJACC: Cardiovascular Interventions
researchProduct

Randomized comparison between the invasive and conservative strategies in comorbid elderly patients with non-ST elevation myocardial infarction.

2016

Abstract Background Comorbid elderly patients with non-ST-elevation myocardial infarction (non-STEMI) are underrepresented in randomized trials and undergo fewer cardiac catheterizations according to registries. Our aim was to compare the conservative and invasive strategies in these patients. Methods Randomized multicenter study, including 106 patients (January 2012–March 2014) with non-STEMI, over 70 years and with comorbidities defined by at least two of the following: peripheral artery disease, cerebral vascular disease, dementia, chronic pulmonary disease, chronic renal failure or anemia. Patients were randomized to invasive (routine coronary angiogram, n = 52) or conservative (coronar…

Malemedicine.medical_specialtyCardiac Catheterizationmedicine.medical_treatmentComorbidityKaplan-Meier Estimate030204 cardiovascular system & hematologyRevascularizationCoronary Angiography03 medical and health sciences0302 clinical medicineInternal medicineInternal MedicineMedicineHumans030212 general & internal medicineMyocardial infarctionProspective StudiesRegistriesAngioplasty Balloon CoronaryProspective cohort studyNon-ST Elevated Myocardial InfarctionCardiac catheterizationAgedProportional Hazards ModelsAged 80 and overbusiness.industryProportional hazards modelCardiovascular Agentsmedicine.diseaseComorbidityTreatment OutcomeSpainHeart failureCardiovascular agentCardiologyFemalebusinessEuropean journal of internal medicine
researchProduct

Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry

2020

Currently, chronic obstructive pulmonary disease (COPD) represents the fourth cause of death worldwide with significant economic burden. Comorbidities increase in number and severity with age and are identified as important determinants that influence the prognosis. In this observational study, we retrospectively analyzed data collected from the RePoSI register. We aimed to investigate comorbidities and outcomes in a cohort of hospitalized elderly patients with the clinical diagnosis of COPD. Socio-demographic, clinical characteristics and laboratory findings were considered. The association between variables and in-hospital, 3-month and 1-year follow-up were analyzed. Among 4696 in-patient…

Malemedicine.medical_specialtyChronic ObstructiveCirrhosisSocio-culturaleComorbidity030204 cardiovascular system & hematologycomorbiditieselderlyPulmonary Disease03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineInternal medicinemedicine80 and overCOPDHumans030212 general & internal medicineLS4_4RegistriesHospital MortalityCOPD comorbidities elderly internal medicine in-hospital mortality.Depression (differential diagnoses)Cause of deathAgedRetrospective Studies1-year mortality; 3-month mortality; COPD; comorbidities; elderly; internal medicine; in-hospital mortalityAged 80 and overCOPDbusiness.industry1-year mortality; 3-month mortality; COPD comorbidities elderly internal medicine in-hospital mortalitymedicine.diseaseIm - Original1-year mortality; 3-month mortality; COPD comorbidities elderly internal medicine in-hospital mortality; Aged; Aged 80 and over; Comorbidity; Female; Humans; Internal Medicine; Male; Pulmonary Disease Chronic Obstructive; Registries; Retrospective Studies; Hospital Mortalityinternal medicineClinical diagnosisCohortEmergency Medicine1-year mortality3-month mortalityCOPD comorbidities elderly internal medicine in-hospital mortality1-year mortality 3-month mortality COPD comorbidities elderly internal medicine in-hospital mortality.Observational studyFemalebusiness1 year mortalityin-hospital mortality
researchProduct

Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study

2000

BACKGROUND—Marked differences in population based survival across Europe were found for colorectal cancers diagnosed in 1985-1989.
AIMS—To understand the reasons for these differences in survival in a new analysis of colorectal cancers diagnosed between 1988 and 1991.
SUBJECTS—A total of 2720 patients with adenocarcinoma of the large bowel from 11 European cancer registries (CRs).
METHODS—We obtained information on stage at diagnosis, diagnostic determinants, and surgical treatment (not routinely collected by CRs) and analysed the data in relation to three year observed survival, calculating relative risks (RRs) of death and adjusting for age, sex, site, stage, and determinants of stage.
RE…

Malemedicine.medical_specialtyColorectal cancerColorectal cancer; Europe; Population based cancer registries; Stage at diagnosis; Surgery; Survival;-AdenocarcinomaArticleInternal medicinemedicineCarcinomaHumansRegistriesStage (cooking)Sex DistributionLetters to the EditorSurvival rateNeoplasm Stagingbusiness.industryGastroenterologyCancermedicine.diseaseConfidence intervalSurgeryEuropeSurvival RateRelative riskAdenocarcinomaFemalebusinessColorectal Neoplasms
researchProduct

Trends in Frequency and Management of Obstructing Colorectal Cancers in a Well-Defined Population

2007

Few population-based studies investigate obstructing colorectal cancers. This study was designed to describe trends in their frequency and management. Data were obtained for 13,331 colorectal cancers registered by the population-based cancer registry of Burgundy, France, between the years 1976 and 2000. Obstructing cancers represented 8.3 percent of all colorectal cancers. This proportion was stable throughout the study. Resection for cure increased from 54.9 percent (1976–1980) to 71.4 percent (1996–2000; P = 0.011). Using multivariate analysis, site of cancer and period of diagnosis were the only factors significantly associated to a curative resection. Postoperative mortality for obstruc…

Malemedicine.medical_specialtyColorectal cancerPopulationAdenocarcinomaGastroenterologySurgical oncologyInternal medicineHumansMedicineHospital MortalityRegistrieseducationMass screeningAgedNeoplasm StagingAged 80 and overeducation.field_of_studybusiness.industryIncidenceIncidence (epidemiology)Age FactorsGastroenterologyCancerGeneral MedicineMiddle Agedmedicine.diseaseColorectal surgeryCancer registryFemaleFranceColorectal NeoplasmsbusinessIntestinal ObstructionDiseases of the Colon & Rectum
researchProduct

Influence of non-clinical factors on restorative rectal cancer surgery: An analysis of four specialized population-based digestive cancer registries …

2022

Abstract Background This study aims to measure the association between deprivation, health care accessibility and health care system with the likelihood of receiving non-restorative rectal cancer surgery (NRRCS). Methods All adult patients who had rectal resection for invasive adenocarcinoma diagnosed between 2007 and 2016 in four French specialised cancer registries were included. A multilevel logistic regression with random effect was used to assess the link between patient and health care structure characteristics on the probability of NRRCS. Results 2997 patients underwent rectal cancer resection in 68 health care structures: 708 (23.63%) had NRRCS. The likelihood of receiving NRCCS was…

Malemedicine.medical_specialtyColorectal cancermedicine.medical_treatmentAdenocarcinomaHealth Services AccessibilityInternal medicineHealth careMedicineHumansRegistriesStage (cooking)Neoadjuvant therapyAgedAged 80 and overLikelihood FunctionsProctectomyHepatologybusiness.industryRectal NeoplasmsProctocolectomy RestorativeGastroenterologyCancerMiddle Agedmedicine.diseaseLogistic ModelsNon clinicalRectal cancer surgeryMultilevel AnalysisAdenocarcinomaFemaleFranceSocial DeprivationbusinessDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study.

2010

An important focus in Alzheimer's disease (AD) research is the development of methods for early diagnosis. Despite progress with some other biomarkers, sensitive and specific neuropsychological measures for identifying subjects in the prodromal phase of AD remain the most promising early diagnostic tool. We evaluated the value of the composite score for the Consortium to Establish a Registry for Alzheimer's disease Neuropsychological Battery (CERAD-NB) in Europeans with mild cognitive impairment (MCI) and in control populations. Baseline clinical data were analyzed from 223 healthy elderly and 224 subjects with MCI from the prospective AddNeuroMed study carried out in Finland, France, Greec…

Malemedicine.medical_specialtyComposite scoreNeuropsychological TestsStatistics NonparametricDevelopmental psychologyProdromal phaseAlzheimer DiseaseInternal medicinemental disordersmedicineHumansRegistriesCognitive impairmentAgedAged 80 and overAnalysis of VarianceGeneral NeuroscienceNeuropsychologyGeneral MedicineHealthy elderlyNeuropsychological batteryEuropePsychiatry and Mental healthClinical PsychologyStatus examinationEarly DiagnosisROC CurveFemaleGeriatrics and GerontologyPsychologyCognition DisordersJournal of Alzheimer's disease : JAD
researchProduct